Clinical Trial Update: Rivastigmine for the Treatment of Hypoactive Anticholinergic Delirium and CNS Depression Associated Mainly With Clozapine Poisoning. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated rivastigmine for treating hypoactive anticholinergic delirium and CNS depression associated with clozapine poisoning; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticholinergic Delirium
• Antipsychotic Toxicity
• Clozapine Poisoning
• Cns Depression
• Delirium
• Hypoactive Delirium
• Procyclidine-induced Delirium
• Tricyclic Antidepressant Poisoning

Drugs mentioned

• Exelon (rivastigmine)

Snippet

Sponsor: Alexandria University | Conditions: Anticholinergic Delirium, Clozapine Poisoning | Phase 4 | Status: COMPLETED